logo

For the Inventor, By the Inventor

Lucca, Italy

Francesco Pietra

This inventor holds 2 USPTO granted patents. Top assignee: Pharmacia & Upjohn. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Pietra. Retrieved from https://idiyas.com/inventor/francesco-pietra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:

goldMedal2 out of 117 
 
Pharmacia & Upjohn
 patents

Years Active: 1999

Loading Chart...
2 patents (USPTO):Explore Patents
1. 5922750 - Terpenoidic derivatives useful as antitumor agents (1999-07-13),
2. 5869514 - Terpenoidic derivatives useful as antitumor agents (1999-02-09),

Title: Francesco Pietra: Innovator in Antitumor Agents

Introduction

Francesco Pietra is a notable inventor based in Lucca, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents, his work is recognized for its potential impact on cancer treatment.

Latest Patents

Francesco's latest patents include innovative terpenoidic derivatives known as Sarcodictyins. These derivatives are recognized for their therapeutic applications, specifically as antineoplastic agents in the treatment of cancers in both humans and animals. His research focuses on the pharmaceutical compositions containing these compounds, which hold promise for advancing cancer therapies.

Career Highlights

Francesco Pietra has established a career at Pharmacia & Upjohn S.p.a., where he has been instrumental in research and development. His work has contributed to the understanding and application of terpenoidic derivatives in medical science. His dedication to innovation in pharmaceuticals has positioned him as a key figure in the industry.

Collaborations

Francesco has collaborated with esteemed colleagues such as Carlo Battistini and Marina Ciomei. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Francesco Pietra's contributions to the field of pharmaceuticals, particularly in the development of antitumor agents, highlight his innovative spirit and dedication to improving cancer treatment. His work continues to inspire advancements in medical research and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…